1. Sagata, Noriaki, Kato, Takahiro A, Kano, Shin-Ichi, Sawa, Akira, Kanba, Shigenobu. 2017. Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study. In Scientific reports, 7, 13905. doi:10.1038/s41598-017-14440-7. https://pubmed.ncbi.nlm.nih.gov/29066822/
2. Garcia-Giralt, Natalia, Roca-Ayats, Neus, Abril, Josep F, Balcells, Susanna, Rabionet, Raquel. 2022. Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment. In Genes, 13, . doi:10.3390/genes13010146. https://pubmed.ncbi.nlm.nih.gov/35052486/
3. Shao, Longjiang, Wang, Jianghua, Karatas, Omer, Ittmann, Michael. 2021. MEX3D is an oncogenic driver in prostate cancer. In The Prostate, 81, 1202-1213. doi:10.1002/pros.24216. https://pubmed.ncbi.nlm.nih.gov/34455614/
4. Zhang, Ming, Cao, Linfeng, Hou, Gouxin, Lv, Xiaodong, Deng, Jingjing. 2022. Investigation of the Potential Correlation Between RNA-Binding Proteins in the Evolutionarily Conserved MEX3 Family and Non-small-Cell Lung Cancer. In Molecular biotechnology, 65, 1263-1274. doi:10.1007/s12033-022-00638-2. https://pubmed.ncbi.nlm.nih.gov/36507941/
5. Yu, Jianfeng, Luo, Jiawei, Li, Pengfei, Zhang, Guowei, Guan, Huaijin. 2022. Identification of the circRNA-miRNA-mRNA Regulatory Network in Pterygium-Associated Conjunctival Epithelium. In BioMed research international, 2022, 2673890. doi:10.1155/2022/2673890. https://pubmed.ncbi.nlm.nih.gov/36398070/
6. Schinke, Ellyn N, Bii, Victor, Nalla, Arun, Meadows, Gary G, Trobridge, Grant D. 2014. A novel approach to identify driver genes involved in androgen-independent prostate cancer. In Molecular cancer, 13, 120. doi:10.1186/1476-4598-13-120. https://pubmed.ncbi.nlm.nih.gov/24885513/
智鼠故事 
